Introduction
Isolated deficiency of IgA is by far the most commonly identified defect of the immune system in humans. The prevalence of this dysgammaglobulinaemia in a Swedish population has been estimated to 1/700 (Bachmann, 1965) . The defect may appear in otherwise healthy persons or may be associated with an increased incidence of infections, particularly respiratory. An increased incidence in malabsorptive states and so-called autoimmune diseases including hepatitis has also been reported. The evolution of secondary IgA deficiency may occur as a part of generalized deficiency of immunoglobulins, as in multiple myeloma or proteinlosing states. Secondary IgA deficiency has also been reported in connection with phenytoin treatment (Aarli and T6nder, 1975) and in patients with ulcerative colitis receiving sulphasalazine treatment (Savilathi and Pelkonen, 1979) .
The purpose of this report is to present a case of isolated symptomatic IgA-deficiency occurring in a woman with hypothyroidism and responding to treatment of the endocrine disease.
Case report
The patient is a woman born in 1919. Her family history is unremarkable. When aged 43 years she had an episode of atrial fibrillation which was treated with quinidine sulphate, and developed an exanthema. At In 1970, the patient was clinically and biochemically euthyroid but her atrial fibrillation persisted. Two attempts to convert to sinus rhythm by DC countershock were unsuccessful and the patient was given acetyldigitoxin 02 mg daily. The skin manifestations and lymphadenopathy disappeared, but the spleen remained slightly enlarged. Her blood picture was, however, normalized.
In 1972 the patient had a right-sided carpal tunnel syndrome which was treated surgically, and the first radioimmunoassay of TSH was performed with a normal result (Fig. 1) .
In 1972 (Bansi, 1955;  de Groot and Stanbury, 1975) . However, to the author's knowledge, this feature has not earlier been found to be associated with IgA-deficiency. Finnish authors (Kuitunen et al., 1971) have noted a high frequency of IgAdeficiency in children with thyroiditis but this has been shown to be a permanent and irreversible deficiency, probably inherited as an autosomal dominant trait. The unique feature of the present case in the evolution of an acquired, clinically significant and reversible IgA-deficiency associated with an iatrogenic (131I) hypothyroidism. As no TRH tests were performed the diagnosis was probably delayed. The carpal tunnel syndrome in 1972 might well have been an early manifestation of myxoedema. In any case, the patient's IgA concentration seems dependent upon her current thyroid status; high when toxic, subnormal when myxoedematous and later restored to normal on adequate substitutions (Fig. 1) . There was no evidence of chronic thyroiditis in the patient, nor other autoimmune diseases, although the side effects of carbimazole and quinidine treatment were suggestive of systemic lupus erythematosus. Absence of L.E. cells, antinuclear factor and the subsequent course, however, exclude this possibility.
IgA-deficiency is not a common feature of hypothyroidism. On reviewing 7 patients with hypothyroidism where individual immunoglobulins had been analysed before and after therapy, no evidence of an association between plasma IgA concentration and thyroid function could be found. The patient's susceptibility to infections constituting a classic sinobronchial syndrome were clearly associated not only with sub-normal plasma IgA but also with sub-normal salivary levels (Table 1) . Thus the patient probably had impaired immune defence in her respiratory tract. The abnormal 14C-cholylglycine breath test indicative of abnormal bacterial overgrowth in the proximal lumen may also be explained by the intestinal IgA deficiency. In this case there was no evidence of impaired lymphocyte or granulocyte function, which may be alternative mechanisms for decreased resistance against infections in hypothyroidism. The data shown in Table 1 together with the clinical course exclude the possibility that the thyroid function determined the production rate of the secretory component which joins 2 IgA molecules together and prevents proteolytic degradation of the dimers. The data given in Table 1 also seem to preclude the possibility of abnormal J-chain production in hypothyroidism. The plasma concentration of the joining chain is normal.
Three further possibilities remain. Antibodies against IgA might have been present either owing to or quite independent of the thyroid dysfunction. Experiments to test this possibility were not performed but it seems improbable that an antibody in vivo should block the specific antibody site used in the immunoassay of the protein in plasma. A drug-induced deficiency seems improbable with regard to the course (Fig. 1) . Finally, the production of the IgA heavy and/or light chains might have been impaired by the hypothyroid state. This could be due to a decrease in IgA-secreting cells or blocked intracellular synthesis. A synthetic failure was substantiated by the lack of IgA-producing cells demonstrated in both bone marrow and rectal biopsies. However, the apparent influence of the thyroid function on the IgA synthetic rate remains unexplainable. 
